1. Home
  2. AGRZ vs GRI Comparison

AGRZ vs GRI Comparison

Compare AGRZ & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agroz Inc. Ordinary Shares

AGRZ

Agroz Inc. Ordinary Shares

HOLD

Current Price

$2.93

Market Cap

3.3M

ML Signal

HOLD

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$1.42

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGRZ
GRI
Founded
2020
2018
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.0M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
AGRZ
GRI
Price
$2.93
$1.42
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $18.50
AVG Volume (30 Days)
★ 198.1K
44.3K
Earning Date
11-03-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.15
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.17
$0.18
52 Week High
$5.34
$64.12

Technical Indicators

Market Signals
Indicator
AGRZ
GRI
Relative Strength Index (RSI) 57.34 35.56
Support Level $2.71 $1.36
Resistance Level $3.78 $2.63
Average True Range (ATR) 0.58 0.12
MACD -0.16 -0.03
Stochastic Oscillator 7.70 10.29

Price Performance

Historical Comparison
AGRZ
GRI

About AGRZ Agroz Inc. Ordinary Shares

Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: